HIV Articles
Back 
Switching to Genvoya + Darunavir in Treatment-Experienced Adult Patients
Strategic Simplification: The Efficacy and Safety of Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Plus Darunavir (DRV) in Treatment-Experienced HIV-1-Infected Adults (NCT01968551)
- (10/13/15)
View Older Articles
Back to Top
www.natap.org